Aman Chauhan, Associate Professor at University of California, San Francisco, shared a post on LinkedIn:
“Check out our panel discussion on extrapulmonary neuroendocrine carcinoma (epNEC)—an aggressive and often underrecognized cancer with significant unmet needs.
Alongside Ryan Haumschild (Emory), William Oh (Yale), Namrata Vijayvergia (Fox Chase), Sandy Kotiah (Mercy Medical) and myself Aman Chauhan (UCSF) we discuss the challenges of diagnosis and care coordination, the burden on patients and caregivers, limitations of current therapies, biomarker testing and access barriers, and the rapidly evolving pipeline of novel treatments—including very exciting T-cell–engaging bispecific antibodies, antibody-drug conjugates, and radiopharmaceuticals.
The future of epNEC care is evolving rapidly, and there is real promise on the horizon.
Other articles featuring Aman Chauhan on OncoDaily.